Cyclophosphamide in the treatment of the nephrotic syndrome in childhood.
D000293:Adolescent; D000367:Age Factors; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D006066:Gonads / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007247:Infertility, Female / Q000139:chemically induced; D007248:Infertility, Male / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D051379:Mice; D009404:Nephrotic Syndrome / Q000150:complications / Q000188:drug therapy*; D010049:Ovarian Diseases / Q000139:chemically induced; D012075:Remission, Spontaneous; D001745:Urinary Bladder Diseases / Q000139:chemically induced; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide